TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock-Reference-Cited by-同舟云学术

TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock

Published:1994-10 Issue:3-4 Volume:42 Page:128-134
ISSN:0065-4299
Container-title:Agents and Actions
language:en
Short-container-title:Agents and Actions

Author:

Canale Patrizia,Squadrito Francesco,Altavilla Domenica,Ioculano Mariapatrizia,Zingarelli Basilia,Campo Giuseppe M.,Urna Giuseppe,Sardella Aurora,Squadrito Giovanni,Capuli Achille P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF01983478.pdf

Reference32 articles.

1. K. M. Mullane, J. A. Salmon and S. Moncada,Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther.282, 510–522 (1984).

2. D. N. Granger, J. N. Benoit, M. Suzuki and M. B. Grisham,Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol.257, (Gastrointest Liver Physiol 20): G683-G688 (1989).

3. P. Canale, F. Squadrito, B. Zingarelli, D. Altavilla, M. Ioculano, G. M. Campo and A. P. Caputi,Splanchnic artery occlusion shock vinblastine-induced leukopenia reduces tumor necrosis factor and thromboxane A 2 formation and increases survival rate. Pharmacol. Res.27, 1–11 (1993).

4. M. Oliver, R. D. Specian, M. A. Perry and D. N. Granger,Morphologic assessment of leukocyte-endothelial cell interaction in mesenteric venules subjected to ischemia and reperfusion. Inflammation15, 331–335 (1991).

5. L. M. Mc Manus, D. J. Hanahan, C. A. Demopoulos and R. N. Pinckard,Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine 2(AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J. Immunol.124, 2919–2924 (1980).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous enteral protease inhibition as a novel treatment for experimental trauma/hemorrhagic shock;European Journal of Trauma and Emergency Surgery;2021-01-22

2. ACTIVATION OF THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY REDUCES NF-κB ACTIVATION, BLUNTS TNF-α PRODUCTION, AND PROTECTS AGAINTS SPLANCHIC ARTERY OCCLUSION SHOCK;Shock;2006-05

3. The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion;Memórias do Instituto Oswaldo Cruz;2005-03

4. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment;British Journal of Pharmacology;2003-06

5. Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating;Methods and Findings in Experimental and Clinical Pharmacology;2002